SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Oppenheimer Maintains Outperform on Ascendis Pharma, Lowers Price Target to $208

Oppenheimer maintains Ascendis Pharma (NASDAQ:ASND) with a Outperform and lowers the price target from $219 to $208.

Benzinga · 05/20/2020 12:23

Oppenheimer maintains Ascendis Pharma (NASDAQ:ASND) with a Outperform and lowers the price target from $219 to $208.